Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Athersys, Inc.    ATHX

ATHERSYS, INC.

(ATHX)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

ATHERSYS, INC / NEW : Change in Directors or Principal Officers (form 8-K)

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/11/2019 | 04:20pm EDT
Item 5.02.   Departure of Directors or Certain Officers; Election of Directors;
             Appointment of Certain Officers; Compensatory Arrangements of
             Certain Officers



On January 11, 2019, the independent members of the Board of Directors of
Athersys, Inc. (the "Company"), upon the recommendation of the Compensation
Committee of the Board of Directors of the Company, approved the following cash
bonuses to the named executive officers of the Company, based on individual
performance and achievement of corporate goals in 2018:
Name                   Title                                          Award
Gil Van Bokkelen       Chief Executive Officer                        $   267,300
William Lehmann, Jr.   President and Chief Operating Officer          $   142,000
                       Executive Vice President and Chief Scientific
John Harrington        Officer                                        $   141,200
Laura Campbell         Senior Vice President of Finance               $    81,100

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ATHERSYS, INC.
06/14ATHERSYS, INC / NEW : Change in Directors or Principal Officers, Submission of M..
AQ
06/04Athersys to Present at Jefferies 2019 Healthcare Conference
GL
05/30ATHERSYS, INC / NEW : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
05/29ATHERSYS : to Participate in four Events at the International Society of Cell an..
AQ
05/28ATHERSYS : to Participate in four Events at the International Society of Cell an..
AQ
05/20ATHERSYS : Presents Data From Its Acute Respiratory Distress Syndrome Clinical T..
AQ
05/14ATHERSYS : Announces Fast Track Designation From FDA for MultiStem® Program for ..
AQ
05/08ATHERSYS : NEW Management's Discussion and Analysis of Financial Condition and R..
AQ
05/08ATHERSYS, INC / NEW : Results of Operations and Financial Condition, Financial S..
AQ
05/08Athersys Reports First Quarter 2019 Results
GL
More news